{"id":"https://openalex.org/W122294597","doi":null,"title":"A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.","display_name":"A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.","publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W122294597","mag":"122294597","pmid":"https://pubmed.ncbi.nlm.nih.gov/2236458"},"language":"en","primary_location":{"id":"pmid:2236458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2236458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068743109","display_name":"Michele T. Pato","orcid":"https://orcid.org/0000-0002-4589-7398","observed_orcids":["https://orcid.org/0000-0002-4589-7398"]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M T Pato","raw_affiliation_strings":["Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD","institution_ids":["https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101846400","display_name":"James Hill","orcid":"https://orcid.org/0000-0003-3178-4402","observed_orcids":["https://orcid.org/0000-0003-3178-4402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J L Hill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032175276","display_name":"D L Murphy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D L Murphy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0936,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.75406795,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26","issue":"2","first_page":"211","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clomipramine","display_name":"clomipramine","score":0.968999981880188},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.7870000004768372},{"id":"https://openalex.org/keywords/long-term-maintenance-therapy","display_name":"long-term maintenance therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.5320000052452087},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.7279999852180481},{"id":"https://openalex.org/keywords/y-bocs","display_name":"Yale-Brown Obsessive Compulsive Scale","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C2779305415","wikidata":"https://www.wikidata.org/wiki/Q58713","display_name":"Clomipramine","level":2,"score":0.9857296943664551},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8234405517578125},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5895349979400635},{"id":"https://openalex.org/C3017582312","wikidata":"https://www.wikidata.org/wiki/Q178190","display_name":"Obsessive compulsive","level":2,"score":0.5806567668914795},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.47858405113220215},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4523036777973175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4453396797180176},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.4185599684715271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3721020221710205},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.1802842915058136},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002997","descriptor_name":"Clomipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2236458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2236458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Clinical Trial"},{"id":"mag:122294597","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2236458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000076205","display_name":"NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM","funder_award_id":"F35HD006930","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"}],"funders":[{"id":"https://openalex.org/F4320337611","display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","ror":"https://ror.org/04byxyr05"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2334756517","https://openalex.org/W2401155439","https://openalex.org/W1664173751","https://openalex.org/W171280510","https://openalex.org/W2271776958","https://openalex.org/W2060325097","https://openalex.org/W2064632477","https://openalex.org/W2063793759","https://openalex.org/W2049055813","https://openalex.org/W1994066493"],"abstract_inverted_index":{"Ten":[0],"patients":[1,34,41,163],"with":[2,12],"DSM-III-R":[3],"obsessive-compulsive":[4],"disorder":[5],"(OCD)":[6],"who":[7],"were":[8,18,35,164,172],"being":[9],"treated":[10],"chronically":[11],"clomipramine":[13,26,54],"(270":[14],"+/-":[15,119],"20":[16],"mg/day)":[17],"studied":[19],"to":[20,28,44,167,174],"determine":[21],"the":[22,37,74,79,85,95,147,187],"minimum":[23,69],"dose":[24,139],"of":[25,39,48,53,71,88,98,117,124,186],"needed":[27],"maintain":[29],"therapeutic":[30],"benefit.":[31],"These":[32,156],"10":[33],"among":[36],"17":[38],"18":[40],"recently":[42],"reported":[43],"develop":[45],"a":[46,114,122],"return":[47],"OC":[49,77,106,149],"symptoms":[50],"following":[51,75],"discontinuation":[52],"under":[55],"double-blind,":[56],"placebo-controlled":[57],"conditions.":[58],"Each":[59],"patient":[60],"was":[61,140],"rated":[62],"twice--open":[63],"and":[64,68,94],"double-blind--at":[65],"both":[66],"initial":[67],"doses":[70,179],"clomipramine,":[72],"using":[73],"three":[76,148],"measures:":[78],"Yale-Brown":[80],"Obsessive":[81],"Compulsive":[82,91],"Scale":[83,92,103],"(YBOCS),":[84],"National":[86,96],"Institute":[87,97],"Mental":[89,99],"Health-Obsessive":[90],"(NIMH-OC),":[93],"Health":[100],"Global":[101,105],"Obsessive-Compulsive":[102],"(NIMH":[104],"Scale).":[107],"Gradual,":[108],"open":[109],"dosage":[110,116],"reduction":[111,123],"resulted":[112],"in":[113,138,146,184],"mean":[115],"165":[118],"19":[120],"mg/day,":[121],"105":[125],"mg/day":[126],"(approximately":[127],"40%,":[128],"t":[129],"=":[130],"5.55,":[131],"p":[132],"less":[133],"than":[134,180],".001).":[135],"This":[136],"decrease":[137],"accompanied":[141],"by":[142,153],"no":[143],"significant":[144],"change":[145],"measures,":[150],"as":[151],"determined":[152],"paired":[154],"t-test.":[155],"results":[157],"suggest":[158],"that":[159],"even":[160],"though":[161],"OCD":[162],"not":[165],"able":[166,173],"discontinue":[168],"medication":[169],"completely,":[170],"they":[171],"do":[175],"well":[176],"at":[177],"lower":[178],"those":[181],"used":[182],"initially":[183],"treatment":[185],"disorder.":[188]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}